Onderneming GreenLight Biosciences Holdings
Aandelen
GRNA
US39536G1058
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Andrey Zarur
CEO | Chief Executive Officer | 54 | - |
Clay Mitchell
PSD | President | - | 24-07-23 |
Drew Cunningham
CTO | Chief Tech/Sci/R&D Officer | - | - |
Amin Khan
CTO | Chief Tech/Sci/R&D Officer | 61 | - |
Nina Thayer
CMP | Compliance Officer | - | 01-03-23 |
Carole Cobb
COO | Chief Operating Officer | 66 | - |
Thomas Crampton
PRN | Corporate Officer/Principal | - | - |
Mark Singleton
PRN | Corporate Officer/Principal | 56 | - |
Charu Manocha
HRO | Human Resources Officer | 57 | 01-01-20 |
Corporate Officer/Principal | 51 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Andrey Zarur
CEO | Chief Executive Officer | 54 | - |
Clay Mitchell
PSD | President | - | 24-07-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 151 681 314 | 119 177 217 ( 78,57 %) | 0 | 78,57 % |
Bedrijfsgegevens
GreenLight Biosciences Holdings PBC
29 Hartwell Avenue
02421, Lexington
+
http://www.greenlightbiosciences.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4,09% | 43,84 mld. | |
+46,85% | 41,25 mld. | |
+9,45% | 41,68 mld. | |
-10,92% | 27,04 mld. | |
+9,32% | 25,53 mld. | |
-24,87% | 18,18 mld. | |
+29,70% | 12,29 mld. | |
+1,28% | 12,29 mld. | |
+7,78% | 11,15 mld. |